Alector to participate in upcoming healthcare conferences

South san francisco, calif., sept. 07, 2022 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming investor conferences:

ALEC Ratings Summary

ALEC Quant Ranking